INVITED COMMENTARY
Linda Harris, MD, Buffalo, NY Dr Miura and colleagues have studied whether tight blood pressure (BP) control with intravenous medication after elective endovascular aneurysm repair (EVAR) might decrease type II endoleak (T2E). They found decreased incidence of T2E and enhanced sac shrinkage at 1 year both in those in whom no T2E developed and even when T2E persisted. They placed all patients in the intensive care unit after elective EVAR. This type of perioperative care is not standard, as most patients undergoing EVAR are not placed in critical care or step-down units unless they develop complications. The movement has been toward shorter hospital stays, with studies looking at same-day discharge. 1 The authors hypothesized that lower BP postoperatively, a time when the patient is somewhat hypercoagulable, leads to thrombosis of the small branches, thereby averting T2E. The concept of preventing T2E at the time of initial procedure is not new, as several groups have assessed models to predict high risk for T2E 2,3 using anatomic features, number and size of patent feeding arteries, and other factors. These groups have then looked at pre-emptive coil embolization to prevent T2Es. [2] [3] [4] Clearly, if we can decrease the need for secondary procedures in EVAR patients, that would be beneficial. The question becomes the cost-benefit ratio. In today's current economic environment, procedures or activities that are not standard of care and are costly are closely scrutinized by hospital administrators. Not every patient will develop a T2E and therefore would not need enhanced BP control to avert this potential problem. The length of time for which tight BP control might be needed is also unclear. Unfortunately, the authors do not have data as to BP control once the patient was discharged. The bigger issue becomes whether BP can be controlled in less expensive settings or by less invasive methods. To make the concept of tight BP control as a method of decreasing T2E feasible financially, these issues would need further exploration before widespread adoption would be considered. Certainly, if tight BP control is as effective as pre-emptive sac embolization, BP control would likely be less expensive, as coils are costly, and would also not interfere with future imaging of the aneurysm sac, nor would it prevent sac shrinkage. This notion of preventing T2E is clearly of interest, as much of surveillance, although geared toward type I and type III endoleaks, is related to T2E and risk of sac expansion. Surveillance and interventions for T2E not only are costly but put patients at risk from radiation exposure. The financial implications of 1 day of tight BP control might be offset by decreased additional interventions in a health care system that looks at cost of care for the disease rather than episodic care. If the findings from this study can be reproduced, a slightly more costly hospital stay might actually be less expensive than frequent radiologic imaging and interventions for T2E and might prove financially feasible. Further validation of these findings is the next obvious step to determine whether postoperative BP control truly has an impact on T2E.
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